Skip to content

Integrated Echocardiography and Chest Ultrasound Assessment of Lung Recruitment in Preterm Infants

Integrated Echocardiography and Chest Ultrasound Assessment of Lung Recruitment in Preterm Infants Using High Frequency Ventilation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05726578
Enrollment
72
Registered
2023-02-14
Start date
2024-07-01
Completion date
2025-07-01
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Ultrasound, Echocardiography, High Frequency Ventilation, Lung Recruitment, Ventilator Lung

Keywords

Premature infants

Brief summary

The primary aim of this work is to evaluate the role of high frequency oscillatory ventilation (HFOV) in recruitment of lung in preterm newborns 32 to 37 weeks gestational age with moderate to severe respiratory distress. The secondary aim is to evaluate the role of chest ultrasound in monitoring of lung recruitment in comparison to routine chest x ray in those babies. Also cardiac hemodynamics will be assesed using functional echocardiography.

Interventions

establishment of lung recruitment using high frequency ventilation and assessment with chest ultrasound and echocardiography

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Hours to 3 Days
Healthy volunteers
No

Inclusion criteria

* Infants will be enrolled if they are 32 to 37 weeks of gestational age, have respiratory distress (RD) in the first 24 h of life, intubated and have invasive respiratory support using HFOV. Signs of RD are tachypnea (respiratory rate \> 60/min), grunting, nasal flaring, chest retraction, and need of oxygen supplementation or other respiratory support.

Exclusion criteria

1. Known major congenital anomalies including congenital heart diseases. 2. Fetal hydrops. 3. Babies with congenital heart diseases

Design outcomes

Primary

MeasureTime frameDescription
chest USfirst 3 days after birthA mobile device (PHILIPS ® HD11 XE) with a 10-MHz linear probe will be used for chest ultrasound the 12 lung zones will be assessed regarding 1. presence Of A lines, B-lines or C-profile 2. presence or absence of pleural sliding
Superior Vena Cava flow in ml/kg/minfirst 3 days of lifeSuperior Vena Cava (SVC) Blood Flow using functional echocardiography
estimated pulmonary artery pressure in mmHgfirst 3 days of lifePulmonary artery pressure (PAP) will be assessed by measuring tricuspid valve regurgitation peak velocity: this will be measured in apical 4 chamber view, with continous wave Doppler using modified Bernoulli equation. Systolic pulmonary artery pressure is equivalent to right ventricular systolic pressure in absence of outflow obstruction. Systolic Pulmonary Artery Pressure (SPAP) = Right Ventricular Systolic Pressure = 4x TR2 + Right Atrial Pressure (RAP), with RAP= 3-5 mmHg.

Countries

Egypt

Contacts

Primary ContactMarwa M Farag, PhD
d.marwa.farag@gmail.com01288681788
Backup ContactMohamed Hany Saad, MBBCh
mohamedhany_90@icloud.com01282226826

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026